Comparison of two different bicarbonate replacement fluids during CVVH with RCA: a prospective, randomized, controlled trial
Intensive Care Medicine · 2025-12 · 51 (12) · 2354-2366
DOI: 10.1007/s00134-025-08175-7 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Intensive Care Medicine, online erschienen am 17.11.2025. Verfasst von Fabian Perschinka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Bicarbonates. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Baxter Healthcare Corporation, University of Innsbruck and Medical University of Innsbruck.
Abstract (Originalsprache)
PURPOSE: This study aimed to compare a high (HBF) and low (LBF) bicarbonate (HCO3-) replacement fluid over 96 h after continuous veno-venous hemofiltration (CVVH) initiation using regional citrate anticoagulation to determine which fluid achieved better acid-base balance. METHODS: In this prospective, randomized, controlled, open-label, cross-over, single-center trial, patients were randomized to initially receive either LBF (22 mmol/l HCO3-) or HBF (30 mmol/l HCO3-) for 48 h (first phase), followed by changing to the other fluid for a further 48 h (second phase). Intracorporeal pH and HCO3- changes were analyzed by calculating the rates of levels outside the standard values (excursion rates). Generalized estimating equations were performed to estimate the odds ratios for at least one pH/HCO3- excursion. Time to normalization within the first phase for pH and HCO3- was assessed using Kaplan-Meier curves and log-rank tests. RESULTS: A total of 88 patients were included. The rates for at least one pH and HCO3- excursion were higher in patients treated with HBF compared to LBF (pH: first phase 52% vs. 41%; second phase 48% vs. 34%; HCO3-: first phase 68% vs. 43%; second phase 73% vs. 43%). Adjusted odds ratios were 1.78 (95% CI 1.12-2.82; p = 0.015) for pH and 3.60 (95% CI 2.16-5.99; p < 0.001) for HCO3-. The time to normalization of pH in acidotic patients and of HCO3- in patients with low HCO3- did not differ significantly between HBF and LBF (p = 0.102, p = 0.468). CONCLUSION: LBF showed significantly lower rates of pH and HCO3- excursions compared to HBF and no significant differences to the pH normalization in acidotic patients were observed. GOV-IDENTIFIER: NCT04071171.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria.
- Institute of Anesthesiology and Critical Care Medicine, Klinikum Wels, Wels, Austria.
- Institute of Clinical Epidemiology, Public Health, Health Economics, Medical Statistics and Informatics, Medical University Innsbruck, Innsbruck, Austria.
- Critical Care Unit, Royal Surrey Hospital, Guildford, UK.
- School of Medicine, University of Surrey, Kate Granger Building, Surrey, Guildford, UK.
- Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria. michael.joannidis@i-med.ac.at.
ORCID-Profile: Fabian Perschinka, Paul Köglberger, Sarah Maier, Hanno Ulmer, Romuald Bellmann, Lui G Forni, Michael Joannidis
Förderung
- Baxter Healthcare Corporation
- University of Innsbruck and Medical University of Innsbruck
Zitieren
APA
Perschinka, F., Köglberger, P., Köhler, A., Lehner, G. F., Peer, A., Maier, S., Ulmer, H., Bellmann, R., Forni, L. G., & Joannidis, M. (2025). Comparison of two different bicarbonate replacement fluids during CVVH with RCA: a prospective, randomized, controlled trial. Intensive Care Medicine, 51(12), 2354-2366. https://doi.org/10.1007/s00134-025-08175-7
Vancouver
Perschinka F, Köglberger P, Köhler A, Lehner GF, Peer A, Maier S, et al. Comparison of two different bicarbonate replacement fluids during CVVH with RCA: a prospective, randomized, controlled trial. Intensive Care Medicine. 2025;51(12):2354-2366. doi:10.1007/s00134-025-08175-7
BibTeX
@article{Perschinka2025,
author = {Perschinka, Fabian and Köglberger, Paul and Köhler, Andrea and Lehner, Georg Franz and Peer, Andreas and Maier, Sarah and Ulmer, Hanno and Bellmann, Romuald and Forni, Lui G and Joannidis, Michael},
title = {Comparison of two different bicarbonate replacement fluids during CVVH with RCA: a prospective, randomized, controlled trial},
journal = {Intensive Care Medicine},
year = {2025},
volume = {51},
number = {12},
pages = {2354--2366},
doi = {10.1007/s00134-025-08175-7}
}
EUVIMED